Identification	identification	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
simple	simple	O	O	O	O
and	and	O	O	O	O
sensitive	sensitive	O	O	O	O
microplate	microplate	O	O	O	O
method	method	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
detection	detection	O	O	O	O
of	of	O	O	O	O
oversulfated	oversulfated	O	O	O	O
chondroitin	chondroitin	O	O	OTHERS	I
sulfate	sulfate	O	O	OTHERS	I
in	in	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
products	products	O	O	O	O
.	.	O	O	O	O

Heparin	heparin	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
commonly	commonly	O	O	O	O
implemented	implemented	O	O	O	O
anticoagulant	anticoagulant	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
treat	treat	O	O	O	O
critically	critically	O	O	OTHERS	I
ill	ill	O	O	OTHERS	I
patients	patients	O	O	O	O
.	.	O	O	O	O

Recently	recently	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
commercial	commercial	O	O	O	O
lots	lots	O	O	O	O
of	of	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
products	products	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
contaminated	contaminated	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
oversulfated	oversulfated	O	O	O	O
chondroitin	chondroitin	O	O	OTHERS	I
sulfate	sulfate	O	O	OTHERS	I
(	(	O	O	O	O
OSCS	oscs	O	O	O	O
)	)	O	O	O	O
derivative	derivative	O	O	O	O
that	that	O	O	O	O
could	could	O	O	O	O
elicit	elicit	O	O	O	O
a	a	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
response	response	O	O	O	O
in	in	O	O	O	O
pigs	pigs	O	O	O	O
following	following	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
high-dose	high-dose	O	O	O	O
infusion	infusion	O	O	O	O
.	.	O	O	O	O

Using	using	O	O	O	O
both	both	O	O	O	O
contaminated	contaminated	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
products	products	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
synthetically	synthetically	O	O	O	O
produced	produced	O	O	O	O
derivative	derivative	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
OSCS	oscs	O	O	O	O
produces	produces	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
pigs	pigs	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
no	no	O	O	O	O
observed	observed	O	O	O	O
effect	effect	O	O	O	O
level	level	O	O	O	O
(	(	O	O	O	O
NOEL	noel	O	O	O	O
)	)	O	O	O	O
for	for	O	O	O	O
this	this	O	O	O	O
contaminant	contaminant	O	O	O	O
appears	appears	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
approximately	approximately	O	O	O	O
1mg/kg	1mg/kg	O	O	O	O
,	,	O	O	O	O
corresponding	corresponding	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
contamination	contamination	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
approximately	approximately	O	O	O	O
3	3	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
also	also	O	O	O	O
demonstrated	demonstrated	O	O	O	O
that	that	O	O	O	O
OSCS	oscs	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
identified	identified	O	O	O	O
in	in	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
products	products	O	O	O	O
using	using	O	O	O	O
a	a	O	O	O	O
simple	simple	O	O	O	O
,	,	O	O	O	O
inexpensive	inexpensive	O	O	O	O
,	,	O	O	O	O
commercially	commercially	O	O	O	O
available	available	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
enzyme	enzyme	O	O	O	O
immunoassay	immunoassay	O	O	O	O
(	(	O	O	O	O
EIA	eia	O	O	O	O
)	)	O	O	O	O
kit	kit	O	O	O	O
that	that	O	O	O	O
has	has	O	O	O	O
a	a	O	O	O	O
limit	limit	O	O	O	O
of	of	O	O	O	O
detection	detection	O	O	O	O
of	of	O	O	O	O
approximately	approximately	O	O	O	O
0.1	0.1	O	O	O	O
%	%	O	O	O	O
,	,	O	O	O	O
well	well	O	O	O	O
below	below	O	O	O	O
the	the	O	O	O	O
NOEL	noel	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
kit	kit	O	O	O	O
may	may	O	O	O	O
provide	provide	O	O	O	O
a	a	O	O	O	O
useful	useful	O	O	O	O
method	method	O	O	O	O
to	to	O	O	O	O
test	test	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
products	products	O	O	O	O
for	for	O	O	O	O
contamination	contamination	O	O	O	O
with	with	O	O	O	O
oversulfated	oversulfated	O	O	O	O
GAG	gag	O	O	O	O
derivatives	derivatives	O	O	O	O
.	.	O	O	O	O

